Focusing on the treatment of dry eye syndrome, corneal ulcers, and dermatology applications, Safetran Rhea Autologous Bio-active Molecules Enrich System (BaM) was certified by the Korea FDA on November 19, 2024, becoming the first fully automatic BaM system recognized by Korea!
Safetran Rhea Autologous Bio-active Molecules Enrich System successfully obtained Korean certification!
